Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 8OTHER_GOV 1NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Leukemia, Myeloid, Acute 4Breast Neoplasms 4Lung Neoplasms 3Neoplasm Metastasis 2Tissue Adhesions 1Solid Tumor Refractory to Standard Therapy 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Sarcoma 1Recurrence 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Platinum Resistant Ovarian Cancer 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Papillomavirus Infections 1Pancreatic Neoplasms 1Ototoxicity 1Neutropenia 1Neoplasms 1Myoma 1Myelodysplastic Syndromes 1Melanoma 1Lymphopenia 1Locally Advanced Cervical Cancer 1Limited Stage Small Cell Lung Cancer 1Leiomyoma 1Hearing Loss 1Febrile Neutropenia 1Fatigue 1

Interventions

pembrolizumab 133Gemcitabine 101Paclitaxel 100Carboplatin 84Nivolumab 66Docetaxel 62Bevacizumab 62Cisplatin 57Pemetrexed 50Fluorouracil 49Cyclophosphamide 41Cetuximab 41trametinib 38venetoclax 37Leucovorin 37Irinotecan 37Sorafenib 35Capecitabine 35Ipilimumab 33Dexamethasone 32atezolizumab 31Erlotinib Hydrochloride 28130-nm albumin-bound paclitaxel 28Drug Therapy 27Epoetin Alfa 26Doxorubicin 25Oxaliplatin 24Albumin-Bound Paclitaxel 24Prednisone 23Rituximab 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Neoplasms × Sodium Chloride × Clear all
NCT01453153 2018-11-30

Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer

Halozyme Therapeutics

Phase 1/2 Completed
28 enrolled 31 charts
Gastrointestinal

Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡